These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8136013)

  • 21. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 22. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myasthenia gravis and neurotransmitters].
    Arimori S
    Nihon Rinsho; 1984 Apr; 42(4):844-9. PubMed ID: 6481980
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoantibodies to acetylcholine receptors in myasthenia gravis.
    N Engl J Med; 1983 Feb; 308(7):402-3. PubMed ID: 6823248
    [No Abstract]   [Full Text] [Related]  

  • 25. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conceptual aspects of myasthenia gravis].
    Ledro Molina D; Avilés Mejías S; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenetic mechanisms in myasthenia gravis.
    Steinman L
    Prog Brain Res; 1990; 84():117-24. PubMed ID: 2267289
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody specificity in myasthenia gravis.
    Vincent A; Wood H
    Monogr Allergy; 1988; 25():33-40. PubMed ID: 3050458
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis.
    Goulon M; Elkharrat D; Lokiec F; Gajdos P
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):211-7. PubMed ID: 3260050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prospects and progress in the studies of neuroimmunology].
    Igata A
    Nihon Rinsho; 1983; 41(4):784-8. PubMed ID: 6350648
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp60 and AChR cross-reactivity in myasthenia gravis: An update.
    Cappello F; Marino Gammazza A; Zummo L; Conway de Macario E; Macario AJ
    J Neurol Sci; 2010 May; 292(1-2):117-8. PubMed ID: 20236663
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 37. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Seronegative' myasthenia gravis is no longer seronegative.
    Lindstrom J
    Brain; 2008 Jul; 131(Pt 7):1684-5. PubMed ID: 18558616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.